Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study.

Department of Medicine, University of California at San Francisco, California 94143-0654, USA.
The Journal of Infectious Diseases (Impact Factor: 5.78). 12/2004; 190(12):2070-6. DOI: 10.1086/425906
Source: PubMed

ABSTRACT In the United States, anal cancer in men who have sex with men (MSM) is more common than cervical cancer in women. Human papillomavirus (HPV) is causally linked to the development of anal and cervical cancer. In women, cervical HPV infection peaks early and decreases after the age of 30. Little is known about the age-specific prevalence of anal HPV infection in human immunodeficiency virus (HIV)-negative MSM.
We studied the prevalence and determinants of anal HPV infection in 1218 HIV-negative MSM, 18-89 years old, who were recruited from 4 US cities. We assessed anal HPV infection status by polymerase chain reaction.
HPV DNA was found in the anal canal of 57% of study participants. The prevalence of anal HPV infection did not change with age or geographic location. Anal HPV infection was independently associated with receptive anal intercourse (odds ratio [OR], 2.0; P<.0001) during the preceding 6 months and with >5 sex partners during the preceding 6 months (OR, 1.5; P<.0001).
Urban, HIV-negative MSM have a stable, high prevalence of anal HPV infection across all age groups. These results differ substantially from the epidemiologic profile of cervical HPV infection in women. This may reflect differences between these populations with respect to the number of new sex partners after the age of 30 and may explain the high incidence of anal cancer in MSM.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Increased anorectal human papillomavirus (HPV) infection is related to the recent trends in sexual behavior in both homosexual and heterosexual groups and prevalence of infection with human immunodeficiency virus (HIV). Clinical presentation and natural history depend on the serotype involved. HPV 6 and 11 are found in the benign wart. Local control can be achieved with a wide selection of surgical and topical techniques. HPV 16, 18, and 31 are found in dysplastic lesions and have the potential to progress to invasive anal squamous cell carcinoma. Recognition and early management of dysplastic lesions is crucial to prevent the morbidity and mortality associated with anal cancer. While low-grade lesions can be closely observed, high-grade lesions should be eradicated. Different strategies can be used to eradicate the disease while preserving anorectal function. Studies on the efficacy of vaccination on anorectal HPV showed promising results in select population groups and led to the recent expansion of current vaccination recommendations.
    The Yale journal of biology and medicine 12/2014; 87(4):537-547.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Aim: Considering that data available on age-specific prevalence of anal human papillomavirus (HPV) infection among men who have sex with men (MSM) are limited and conflicting, we aimed to assess the age-related trend of this infection in HIV-uninfected MSM. Materials & methods: Anal samples, collected using a Dacron swab, were analyzed by the Linear Array HPV Genotyping Test (Roche Diagnostics, Milan, Italy). Results: Among the 408 males enrolled, HPV prevalence was 72.8% and did not significantly change across ages both for any (p = 0.506) and high-risk genotypes (p = 0.588). HPV prevalence by age group did not vary also after adjusting for median number and median age of recent partners. Conclusion: Among urban MSM at risk for sexually transmitted infections, this stability in anal HPV prevalence across all ages may be driven by multiple partnerships in association with sexual mixing across all age groups. Interventions to increase awareness of lifetime HPV risk and willingness to adopt preventive measures may reduce HPV-associated health burden in MSM.
    Future Microbiology 07/2014; 9(7):837-44. DOI:10.2217/fmb.14.44 · 4.02 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: HIV infection is one of the strongest risk factors for anal squamous cell cancer (ASCC). Most ASCC are caused by HPV, and most HPV-associated ASCC are caused by HPV-16. Anal HPV infections are very common in men who have sex with men (MSM), and nearly universal among HIV-infected MSM. High-grade anal intraepithelial neoplasia (HGAIN), the precursor for ASCC, is present in about 30 % of HIV+ MSM, but neither the progression rate to ASCC nor the regression rate are known. The incidence rate of ASCC among HIV-infected people has risen in the first decade after cART became available, but appears to be plateauing recently. Anal cytology has poor sensitivity and specificity. High resolution anoscopy (HRA) is advocated by some as a screening tool in high-risk groups, but is cumbersome and time-consuming and it is unknown whether HRA followed by treatment of HGAIN prevents ASCC. More research is needed on progression and regression rates of HGAIN, on effective therapy of HGAIN, and on biomarkers that predict HGAIN or anal cancer. HPV vaccination and earlier start of cART may prevent most anal cancers in the long run.
    Current HIV/AIDS Reports 07/2014; DOI:10.1007/s11904-014-0224-x